YOLFTbeta
Outset Medical Inc

Outset Medical Inc

OM · NASDAQ · Healthcare / Medical Devices

3.73USD-0.13 (-3.37%)

Price History

Full chart

Market Stats

Previous Close3.86
Open3.85
Day Range3.68 – 3.86
52-Week Range2.84 – 16.16
Volume59.42K
Market Cap57.33M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.80
Dividend Yield0.00%
Beta1.90
50-Day Avg4.05
200-Day Avg4.18

About

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Leslie L. Trigg
  • Employees310
  • Headquarters3052 Orchard Drive, San Jose, CA, United States, 95134, USA
  • Websitehttps://www.outsetmedical.com

Leadership

  • Ms. Leslie L. TriggPresident, CEO & Chairman · b. 1971
  • Ms. Renee M. GaetaCFO, Principal Financial Officer & Principal Accounting Officer · b. 1981
  • Mr. John L. Brottem J.D.General Counsel & Secretary · b. 1974

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.01M15.08M49.94M102.60M115.38M130.38M113.69M119.48M
Growth (%)-+651.27%+231.18%+105.47%+12.45%+13.00%-12.80%+5.09%
Cost of Revenue8.12M32.88M62.97M94.99M97.54M101.38M75.13M72.72M
Gross Profit-6.12M-17.80M-13.04M7.61M17.83M29.00M38.56M46.75M
Gross Margin-304.68%-118.07%-26.11%7.42%15.46%22.24%33.92%39.13%
Operating Expense40.45M52.51M104.43M138.13M178.85M198.77M151.94M113.47M
Operating Income-46.56M-70.31M-117.47M-130.52M-161.02M-169.77M-113.38M-66.71M
Operating Margin-2320.03%-466.29%-235.24%-127.21%-139.56%-130.22%-99.72%-55.84%
EBITDA-43.62M-62.09M-114.31M-124.86M-152.81M-153.79M-102.09M-62.37M
EBITDA Margin-2173.49%-411.77%-228.91%-121.69%-132.45%-117.96%-89.80%-52.21%
Net Income-49.78M-68.30M-120.70M-131.94M-162.96M-172.80M-127.98M-81.65M
Net Income Margin-2480.32%-452.97%-241.71%-128.59%-141.24%-132.54%-112.57%-68.34%
R&D22.92M23.33M28.85M36.74M48.85M57.31M38.40M21.23M
R&D as % of Total Revenue1141.80%154.71%57.78%35.81%42.34%43.96%33.77%17.77%
Interest Expense4.64M4.26M2.37M1.72M3.57M12.68M23.87M13.95M
Interest Expense % of Total Revenue231.14%28.23%4.74%1.67%3.09%9.72%21.00%11.68%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets151.13M88.37M403.83M463.46M400.12M313.80M275.80M264.50M
Total Liabilities439.08M460.55M75.22M89.38M154.13M190.91M248.98M137.54M
Total Equity-287.95M-372.19M328.61M374.08M245.99M122.89M26.82M126.95M
Cash33.26M36.93M294.97M182.35M73.22M68.51M124.01M35.01M
Total Debt28.86M29.06M38.60M37.81M103.23M136.19M201.86M101.25M
Net Debt-4.40M-7.87M-256.37M-144.54M30.01M67.68M77.84M66.24M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-46.44M-70.29M-99.02M-130.26M-145.73M-131.37M-116.30M-46.33M
Investing Cash Flow-68.78M74.30M3.95M-142.51M-66.30M83.03M103.94M-97.68M
Financing Cash Flow134.87M249.00K385.68M160.15M72.90M43.65M67.87M55.50M
Capital Expenditure1.77M3.29M9.11M3.11M8.32M3.44M912.00K798.00K
Free Cash Flow-48.21M-73.58M-108.12M-133.37M-154.05M-134.81M-117.22M-47.13M
FCF to OCF103.80%104.68%109.20%102.39%105.71%102.62%100.78%101.72%

Earnings

Report DateSep 16, 2020Nov 11, 2020Mar 9, 2021May 5, 2021Aug 5, 2021Nov 3, 2021Feb 16, 2022May 4, 2022Aug 1, 2022Nov 8, 2022Feb 13, 2023May 3, 2023Aug 2, 2023Nov 7, 2023Feb 21, 2024May 8, 2024Aug 7, 2024Nov 6, 2024Feb 19, 2025May 7, 2025Aug 6, 2025Nov 10, 2025Feb 11, 2026May 7, 2026Aug 6, 2026Nov 9, 2026
EPS Estimate-2.58-27.37-0.66-12.05-10.08-10.29-10.01-9.93-8.93-10.57-11.19-10.35-10.89-10.00-9.22-8.23-6.79-6.32-6.19-0.94-0.98-0.65-0.67-0.79-0.88-0.84
EPS Actual-0.50-32.71-0.75-8.40-8.55-8.85-11.55-10.05-11.55-10.50-10.65-10.80-10.35-10.65-8.85-8.55-7.05-5.85-5.55-3.24-0.84-0.69-0.84-0.83-0.94-
Surprise80.62%-19.51%-13.64%30.29%15.18%13.99%-15.38%-1.21%-29.34%0.66%4.83%-4.35%4.96%-6.50%4.01%-3.89%-3.83%7.44%10.34%-244.68%14.29%-6.15%-25.37%-5.06%-6.82%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap57.33M
Enterprise Value15.53M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.49
Price / Book0.60
EPS-3.80
Book Value5.13
Revenue (TTM)117.80M
Gross Profit (TTM)49.20M
EBITDA-62.73M
Profit Margin-63.06%
Operating Margin-49.55%
Return on Equity-59.17%
Return on Assets-15.54%
Shares Outstanding18.80M
Shares Float14.77M
Beta1.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 7.67
  • Strong Buy
    3
  • Hold
    2

Ownership Breakdown

Institutions
73.91%
Insiders
5.46%
Retail / Other
20.63%

Top Institutional Holders

  • FMR Inc
    2.74M14.59%
  • BML Capital Management LLC
    2.52M13.40%
  • BlackRock Inc
    1.26M6.72%
  • Bank of America Corp
    949.40K5.05%
  • Perceptive Advisors LLC
    833.33K4.43%
  • AQR Capital Management LLC
    808.28K4.30%
  • Vanguard Capital Management, LLC
    763.82K4.06%
  • Partner Fund Management LP
    582.12K3.10%
  • Ensign Peak Advisors Inc
    526.59K2.80%
  • Geode Capital Management, LLC
    421.37K2.24%
  • Assenagon Asset Management SA
    339.44K1.81%
  • State Street Corp
    334.99K1.78%
  • Peapod Lane Capital LLC
    331.95K1.77%
  • Woodline Partners LP
    292.44K1.56%
  • UBS Group AG
    252.50K1.34%
  • Renaissance Technologies Corp
    222.07K1.18%

Top Fund Holders

  • Fidelity Select Health Care
    1.52M8.09%
  • Fidelity Advisor Health Care I
    800.00K4.26%
  • Vanguard MStar Total Stk Mkt Idx Invest
    552.83K2.94%
  • Fidelity VIP Health Care Initial
    280.00K1.49%

Stock Splits

  • Mar 20, 20251:15